Another Talcum Powder Lawsuit Trial Concludes, as New Jersey Jury Awards $37 Million to Mesothelioma Plaintiff, Bernstein Liebhard LLP Reports

NEW YORK, April 6, 2018 /PRNewswire/ -- Johnson & Johnson and Imery's Talc America have been ordered to pay $37 million to a New Jersey man who was diagnosed with mesothelioma following years of talcum powder use.

Yesterday's verdict in Middlesex County Superior Court followed more than two months of testimony and marked the first time a Plaintiff has prevailed in a talcum powder lawsuit involving Johnson & Johnson's Baby Powder and the often-deadly form of cancer.  In the course of the trial, jurors were shown numerous internal documents indicating that, as early as 1969, the Defendants were concerned that Baby Powder could be tainted by asbestos.

The 7-person jury deliberated for less than a day before finding Johnson & Johnson 70% liable for the Plaintiff's damages, while Imery's was found 30% liable. Jurors will reconvene next week to decide whether the companies should be assessed any punitive damages. (Case No. MID-L-7385-16)

"Our Firm is representing numerous women who allegedly developed ovarian cancer due to their long-term use of Johnson & Johnson talc-based powders for feminine hygiene purposes and we have been monitoring this proceeding very closely," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated Johnson & Johnson's talc-based powders.

Talcum Powder Ovarian Cancer Litigation

More than 6,600 talcum powder lawsuits have been filed against Johnson & Johnson on behalf of women who were diagnosed with ovarian cancer following years of genital talc use. Plaintiffs involved in this litigation have cited numerous studies published since the 1970s suggesting that the regular and repeated application of talc-based powders to the female genitals increased a woman's risk for the often-deadly disease.

The complaints also cite numerous internal documents as evidence that Johnson & Johnson officials were aware of this research but chose not to warn consumers in order to protect profits derived from sales of its Baby Powder and Shower-to-Shower products.

Missouri's 22nd Circuit Court in St. Louis – home to one of the nation's largest talcum powder ovarian cancer litigation -- began trying talcum powder lawsuits in February 2015. So far, four plaintiffs have been awarded compensatory and punitive damages amounting to $110 million, $70 million, $72 million and $55 million.  (Case No. 1422-CC09326-01)

While the $72 million verdict was overturned in October, a state court judge refused to dismiss the $110 million award in December.

California completed its first talcum powder ovarian cancer trial in September, when a Los Angeles Superior Court jury awarded the Plaintiff $417 million, including $340 million in punitive damages. However, that verdict was later dismissed by the trial judge. (Case No. BC628228)

Women who were diagnosed with ovarian cancer following the long-term use of talc-based powders for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs' firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
800-511-5092

ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information: 
Sandy A. Liebhard, Esq. 
Bernstein Liebhard LLP 
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/   
https://plus.google.com/115936073311125306742?rel=author

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com